Page last updated: 2024-10-21

tacrine and Neuroblastoma

tacrine has been researched along with Neuroblastoma in 22 studies

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research Excerpts

ExcerptRelevanceReference
" The present paper reports data regarding the evaluation on the activity of monoamine-oxidase A and B in murine neuroblastoma cells carried out by a radioassay upon acute or chronic treatment of cells by aluminium or tacrine."7.70Evaluation of MAO activities on murine neuroblastoma cells upon acute or chronic treatment with aluminium (III) or tacrine. ( Nicosia, V; Zambenedetti, P; Zatta, P, 1998)
"The effect of chronic treatment with the cholinesterase inhibitor tacrine on nicotinic receptor subtypes was investigated in human SH-SY5Y neuroblastoma cells and in a fibroblast cell line (M10 cells) stably transfected with alpha4beta2 nicotinic receptors."7.70Tacrine interacts with different sites on nicotinic receptor subtypes in SH-SY5Y neuroblastoma and M10 cells. ( Svensson, AL, 2000)
" The present paper reports data regarding the evaluation on the activity of monoamine-oxidase A and B in murine neuroblastoma cells carried out by a radioassay upon acute or chronic treatment of cells by aluminium or tacrine."3.70Evaluation of MAO activities on murine neuroblastoma cells upon acute or chronic treatment with aluminium (III) or tacrine. ( Nicosia, V; Zambenedetti, P; Zatta, P, 1998)
" In silico predicted ADME and physicochemical properties of conjugates showed good CNS bioavailability and safety parameters."2.44Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies. ( Abd El-Wahab, HAA; Akincioglu, H; Gülçin, İ; Omar, FA; Soliman, AM, 2024)
"Tacrine treatment did not alter the level of HSP-70 in cell extracts and tacrine affected mildly the secretion of PN-1."1.29Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines. ( Farlow, MR; Lahiri, DK; Lewis, S, 1994)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (36.36)18.2507
2000's5 (22.73)29.6817
2010's5 (22.73)24.3611
2020's4 (18.18)2.80

Authors

AuthorsStudies
Marco-Contelles, J2
León, R3
de Los Ríos, C3
Guglietta, A1
Terencio, J1
López, MG4
García, AG4
Villarroya, M4
González-Muñoz, GC1
Arce, MP1
López, B1
Pérez, C1
Conde, S1
Rodríguez-Franco, MI1
Li, SY1
Wang, XB1
Xie, SS2
Jiang, N2
Wang, KD2
Yao, HQ1
Sun, HB1
Kong, LY2
Wang, X1
Yu, W1
Lan, JS1
Li, ZR1
Güleç, Ö1
Türkeş, C1
Arslan, M1
Demir, Y1
Yeni, Y1
Hacımüftüoğlu, A1
Ereminsoy, E1
Küfrevioğlu, Öİ1
Beydemir, Ş1
Moreira, NCDS2
Tamarozzi, ER2
Lima, JEBF2
Piassi, LO2
Carvalho, I2
Passos, GA2
Sakamoto-Hojo, ET2
Uliassi, E1
Bergamini, C1
Rizzardi, N1
Naldi, M1
Cores, Á1
Bartolini, M1
Carlos Menéndez, J1
Bolognesi, ML1
Soliman, AM1
Abd El-Wahab, HAA1
Akincioglu, H1
Gülçin, İ1
Omar, FA1
Mitchell, RM1
Lee, SY1
Simmons, Z1
Connor, JR1
Muñoz-Torrero, D1
Pera, M1
Relat, J1
Ratia, M1
Galdeano, C1
Viayna, E1
Sola, I1
Formosa, X1
Camps, P1
Badia, A1
Clos, MV1
Zhang, BF1
Peng, FF1
Zhang, JZ1
Wu, DC1
Orozco, C1
Arias, E1
Marco, JL1
Lahiri, DK3
Lewis, S1
Farlow, MR3
Walker, TM1
Starr, B1
Dewhurst, BB1
Atterwill, C1
Zatta, P2
Zambenedetti, P2
Marturano, MB1
Palumbo, M1
Nicolini, M1
Nicosia, V1
De Ferrari, GV1
von Bernhardi, R1
Calderón, FH1
Luza, SC1
Inestrosa, NC1
Sambamurti, K1
Svensson, AL1
Robbins, J1
Sim, JA1

Other Studies

22 other studies available for tacrine and Neuroblastoma

ArticleYear
Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer's disease.
    Journal of medicinal chemistry, 2006, Dec-28, Volume: 49, Issue:26

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Calcium; Calcium Channels; Cell Prol

2006
Old phenothiazine and dibenzothiadiazepine derivatives for tomorrow's neuroprotective therapies against neurodegenerative diseases.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:12

    Topics: Humans; Molecular Structure; Neuroblastoma; Neurodegenerative Diseases; Neuroprotective Agents; Oxid

2010
Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
    European journal of medicinal chemistry, 2013, Volume: 69

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Biphenyl Compounds; Cell Line, Tumo

2013
Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease.
    European journal of medicinal chemistry, 2015, May-05, Volume: 95

    Topics: Acetylcholinesterase; Alzheimer Disease; Benzopyrans; Blood-Brain Barrier; Brain; Cell Survival; Cel

2015
Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif.
    Molecular diversity, 2022, Volume: 26, Issue:5

    Topics: Acetazolamide; Acetylcholinesterase; Amides; Anticonvulsants; Antineoplastic Agents; Carbonic Anhydr

2022
Novel Dual AChE and ROCK2 Inhibitor Induces Neurogenesis via PTEN/AKT Pathway in Alzheimer's Disease Model.
    International journal of molecular sciences, 2022, Nov-26, Volume: 23, Issue:23

    Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Humans; Neuroblastoma

2022
Novel Dual AChE and ROCK2 Inhibitor Induces Neurogenesis via PTEN/AKT Pathway in Alzheimer's Disease Model.
    International journal of molecular sciences, 2022, Nov-26, Volume: 23, Issue:23

    Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Humans; Neuroblastoma

2022
Novel Dual AChE and ROCK2 Inhibitor Induces Neurogenesis via PTEN/AKT Pathway in Alzheimer's Disease Model.
    International journal of molecular sciences, 2022, Nov-26, Volume: 23, Issue:23

    Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Humans; Neuroblastoma

2022
Novel Dual AChE and ROCK2 Inhibitor Induces Neurogenesis via PTEN/AKT Pathway in Alzheimer's Disease Model.
    International journal of molecular sciences, 2022, Nov-26, Volume: 23, Issue:23

    Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Humans; Neuroblastoma

2022
Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease.
    Bioorganic & medicinal chemistry, 2023, 08-15, Volume: 91

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cholinesterase Inhibit

2023
Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies.
    Bioorganic chemistry, 2024, Volume: 142

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Carboxylic Acids; Cholinest

2024
HFE polymorphisms affect cellular glutamate regulation.
    Neurobiology of aging, 2011, Volume: 32, Issue:6

    Topics: Analysis of Variance; Calcium; Cell Line, Tumor; Deferoxamine; Enzyme Inhibitors; Ferric Compounds;

2011
Expanding the multipotent profile of huprine-tacrine heterodimers as disease-modifying anti-Alzheimer agents.
    Neuro-degenerative diseases, 2012, Volume: 10, Issue:1-4

    Topics: Aminoquinolines; Analysis of Variance; Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relat

2012
[Protective effects of tacrine and donepezil against staurosporine-induced apoptotic death].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2002, Volume: 37, Issue:2

    Topics: Animals; Apoptosis; Cholinesterase Inhibitors; Donepezil; Glioma; HeLa Cells; Humans; Hybrid Cells;

2002
ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective properties.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e

2004
New multipotent tetracyclic tacrines with neuroprotective activity.
    Bioorganic & medicinal chemistry, 2006, Dec-15, Volume: 14, Issue:24

    Topics: Acetylcholinesterase; Calcium; Cholinesterase Inhibitors; Cytosol; Humans; L-Lactate Dehydrogenase;

2006
Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines.
    Journal of neuroscience research, 1994, Apr-15, Volume: 37, Issue:6

    Topics: Amyloid beta-Protein Precursor; Animals; Cell Differentiation; Cell Line; Cholinesterase Inhibitors;

1994
Potential neurotoxicity of a novel aminoacridine analogue.
    Human & experimental toxicology, 1995, Volume: 14, Issue:6

    Topics: Aminoacridines; Analysis of Variance; Animals; Behavior, Animal; Cholinesterase Inhibitors; Explorat

1995
Effects of tacrine upon murine neuroblastoma cells.
    Journal of neural transmission. General section, 1995, Volume: 102, Issue:2

    Topics: Alzheimer Disease; Animals; Mice; Microscopy, Electron, Scanning; Mitosis; Neuroblastoma; Neurofilam

1995
Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines.
    Journal of molecular neuroscience : MN, 1996,Spring, Volume: 7, Issue:1

    Topics: Amyloid beta-Protein Precursor; Animals; Arecoline; Astrocytes; Atropine; Calcimycin; Carbachol; Cho

1996
Evaluation of MAO activities on murine neuroblastoma cells upon acute or chronic treatment with aluminium (III) or tacrine.
    Neurochemistry international, 1998, Volume: 32, Issue:3

    Topics: Aluminum; Animals; Carbon Radioisotopes; Enzyme Activation; Leucine; Mice; Monoamine Oxidase; Neurob

1998
Responses induced by tacrine in neuronal and non-neuronal cell lines.
    Journal of neuroscience research, 1998, May-15, Volume: 52, Issue:4

    Topics: Animals; Cell Differentiation; Cell Size; Dose-Response Relationship, Drug; Glioma; Mice; Neuroblast

1998
The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells.
    Brain research. Molecular brain research, 1998, Nov-20, Volume: 62, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endope

1998
Tacrine interacts with different sites on nicotinic receptor subtypes in SH-SY5Y neuroblastoma and M10 cells.
    Behavioural brain research, 2000, Volume: 113, Issue:1-2

    Topics: Animals; Cell Line; Humans; Mice; Neuroblastoma; Receptors, Nicotinic; Tacrine; Tumor Cells, Culture

2000
A transient outward current in NG108-15 neuroblastoma x glioma hybrid cells.
    Pflugers Archiv : European journal of physiology, 1990, Volume: 416, Issue:1-2

    Topics: 4-Aminopyridine; Action Potentials; Adrenergic Fibers; Animals; Barium; Calcium; Elapid Venoms; Glio

1990